Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nektar To Present REZOLVE-AD Phase 2b Results For Rezpegaldesleukin In Atopic Dermatitis At EADV 2025 Late-Breaker Oral Session On Sept 18 In Paris

Author: Benzinga Newsdesk | September 09, 2025 07:04am

Posted In: NKTR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist